Hypertension and Diabetes: Critical Comorbidities

Abstract

Get full access to this article

View all access options for this article.

References

Lago

R.M.

, Singh

P.P.

, Nesto

R.W.

Diabetes and hypertension. Nat Clin Pract Endocrinol Metab 2007; 3: 667–668.

Wild

, Roglic

, Green

, Sicree

, King

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047–1053.

King

, Aubert

R.E.

, Herman

W.H.

Global burden of diabetes, 1995–2025: prevalence, numerical estimates and projections. Diabetes Care 1998; 21: 1414–1431.

Adler

A.I.

, Stratton

I.M.

, Neil

H.A.

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000; 321: 412–419.

National High Blood Pressure Education Program Working Group report on hypertension in diabetes. Hypertension 1994; 23: 145–158.

Marrilakis

, Bakris

Diabetic hypertensive patients: improving their prognosis. J Cardiovasc Pharmacol 1998; 31(Suppl. 2): S34–S40.

Arauz-Pacheco

Treatment of hypertension in adults with diabetes. Diabetes Care 2003; 26(Suppl. 1): S80–S82.

Cooper

M.E.

, Johnston

C.I.

Optimizing treatment of hypertension in patients with diabetes. JAMA 2000; 283: 3177–3179.

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ 1998; 317: 703–713.

10.

Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK prospective Diabetes Study Group. BMJ 1998; 317: 713–720.

11.

Effect of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus; results of the HOPE study and MICRO-HOPE sub study. Heart Outcomes Prevention Evaluation (HOPE) Investigators. Lancet 2000; 355: 253–259.

12.

Stults

, Jones

R.E.

The treatment of hypertension in adult patients with diabetes. Diabetes Care 2002; 25: 134–147.

13.

Epstein

, Sowers

J.R.

Diabetes mellitus and hypertension. Hypertension 1992; 19: 403–418.

14.

Joint National Committee. The fifth report of the Joint National Committee on detection, evaluation and treatment of high blood pressure. Arch Intern Med 1993; 153: 154–183.

15.

Modan

, Halkin

, Almog

Fuchs z. Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest 1985; 75: 809–817.

16.

Viverti

G.C.

, Keen

, Wiseman

M.J.

Raised arterial pressure in parents of proteinuric insulin-dependent diabetics. BMJ 1987; 295: 575–577.

17.

Sawecki

P.T.

, Kaiser

, Heinemann

, Franzel

, Berger

Prevalence of renal artery stenosis in diabetes mellitus: an autopsy study. J Intern Med 1991; 229: 489–492.

18.

National Stroke Association. Stroke prevention: the importance of risk factors. Stroke: Clin Updates 1991; 1: 17–20.

19.

Curb

J.D.

, Pressel

S.L.

, Cutler

J.A.

Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA 1996; 276: 1886–1892.

20.

Tuomilehto

, Rastenyte

, Birkenhager

W.H.

Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. N Engl J Med 1999; 340: 677–684.

21.

Group UKPDS. UK Prospective Diabetes Study 38: tight blood pressure control and risk of macrovascular and microvascular complications in type II diabetes. BMJ 1998; 317: 703–713.

22.

Hansson

, Zanchetti

, Carruthers

S.G.

Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment randomized trial. Lancet 1998; 351: 1755–1762.

23.

Schrier

R.W.

, Estacio

R.O.

, Esler

, Mehler

Effects of aggressive blood pressure control in normotensive type 2 diabetics on albuminuria, retinopathy and strokes. Kidney Int 2002; 61: 1086–1097.

24.

National Kidney Foundation. Guideline 8: pharmacological therapy: diabetic kidney disease. Am J Kidney Dis 2004; 43(Suppl. 1): S142–S159.

25.

American Diabetes Association. Standards of medical care in diabetes (Position Statement). Diabetes Care 2005; 28(Suppl. 1): S4–S36.

26.

European Societies of Hypertension and Cardiology. Guidelines for the management of arterial hypertension, 2003. J Hypertens 2003; 21: 1011–1052.

27.

Chobanian

A.V.

, Bakris

G.L.

, Black

H.R.

Seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertension 2003; 42: 1206–1252.

28.

Saydah

S.H.

, Fradkin

, Cowie

C.C.

Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004; 291: 335–342.

29.

McFarlane

S.I.

, Castro

, Kaur

Control of blood pressure and other cardiovascular risk factors at different practice settings: outcomes of care provided to diabetic women compared to men. J Clin Hypertens 2005; 7: 73–80.

30.

Grant

R.W.

, Buse

J.B.

, Meigs

J.B.

Quality of diabetes care in U.S. academic medical centers: low rates of medical regimen change. Diabetes Care 2005; 28: 337–342.

31.

Hemmelgarn

B.R.

, McAlister

F.A.

, Myers

M.G.

The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension. Can J Cardiol 2005; 21: 645–656.

32.

Whelton

P.K.

, He

, Appel

L.J.

The National Blood Pressure Education Program Coordinating Committee: Primary prevention of hypertension: clinical and public health advisory from the National High Blood Pressure Education Program. JAMA 2002; 288: 1882–1888.